Fluvoxamine Maleate is a selective neuronal serotonin reuptake inhibitor with a 100-fold affinity for the serotonin transporter over the norepinephrine transporter. It is an aralkylketone-derivative agent developed by Solvay, Belgium. It inhibits many cytochrome P450 enzymes. The compound has been used in preclinical animal study models as a test compound to determine its solubility and permeability attributes. It can be used to develop an HPLC method for compound determination in the presence of its degradation products.
Fluvoxamine Maleate is sparingly soluble in water, and freely soluble in ethanol, methanol, and DMSO.
